𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose-dense therapy improves survival in aggressive non-Hodgkin’s lymphoma

✍ Scribed by Michael A. Fridrik; Hubert Hausmaninger; Alois Lang; Johannes Drach; Otto Krieger; Dietmar Geissler; Gerhard Michlmayr; Ernst Ulsperger; Andreas Chott; Wilhelm Oberaigner; Richard Greil

Publisher
Springer
Year
2009
Tongue
English
Weight
174 KB
Volume
89
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HOAP-Bleo as salvage therapy for diffuse
HOAP-Bleo as salvage therapy for diffuse aggressive non-Hodgkin's lymphoma
✍ R. Liang; D. Todd; T. K. Chan 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 254 KB

A total of 30 patients with recurrent or unresponsive diffuse, aggressive non-Hodgkin's lymphoma, who had previously received doxorubicin, cyclophosphamide, vincristine, and prednisone with or without bleomycin were treated with a combination of doxorubicin, vincristine, ara C, prednisone, and bleom

Prophylactic intrathecal methotrexate an
Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma
✍ Naoto Tomita; Fumio Kodama; Heiwa Kanamori; Shigeki Motomura; Yoshiaki Ishigatsu 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

## Background: Central nervous system (cns) recurrence is almost invariably fatal in patients with aggressive non-hodgkin lymphoma (nhl). although some protocols are intended to prevent cns disease, the value of cns prophylaxis in patients with aggressive nhl remains to be determined. ## Methods: